Vaccine for Brain Tumors Shows Promising Results

November 16, 2006

A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain, known as glioma, has shown promising results in preliminary data from a clinical trial at UCSF Medical Center. Findings from the first group of six patients in ...

An Accurate, Straightforward Method to Predict Prostate Cancer Risk

November 15, 2006

A novel method for predicting the risk of prostate cancer recurrence following surgery that was developed by urologists at UCSF Medical Center has been validated in a recent study. The new method is named the UCSF Cancer of the Prostate Risk Assessment (CAPRA). It is ...

Elderly, Ill Men Get Unneeded Prostate Cancer Screenings

November 14, 2006

A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen (PSA) screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age. Screening rates declined with age, ...

New Drugs Target Treatment-Resistant Leukemia

November 9, 2006

The drug imatinib (Gleevec) is generally considered to be the most significant new entrant in the armamentarium of anticancer drugs in the past 20 years. Its approval in May 2001 was the cover story of Time magazine. In patients whose cancers had grown despite earlier ...

Cancer-Preventing Benefits of the Traditional Asian Diet

October 31, 2006

Studies show that Asian populations have a lower incidence of chronic diseases, such as cancer, than their Western counterparts. One such study, by the National Cancer Institute, found that whites had a 65 percent higher rate of cancer mortality than Asian-Pacific Islanders from the years ...

Jim Wells: Helping to Fill the Drug Discovery Pipeline

October 27, 2006

Cancer, diabetes, inflammation, malaria. The list of diseases ripe for new treatments is long. Yet the pace of drugs coming to market is actually flat. A key reason is the drug discovery process itself, says Jim Wells, director of the Small Molecule Discovery Center (SMDC) ...